Recently, the American Medical Association (AMA) published a list of coding additions and changes for a variety of vaccines, the first since January 1st of this year. This update includes revisions to three existing codes and the addition of two new codes, one of which will not go into effect until next year.

Code 90620, previously “Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB), 2 dose schedule, for intramuscular use,” has been updated to “Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB- 4C), 2 dose schedule, for intramuscular use.”

Code 90621, previously “Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB), 3 dose schedule, for intramuscular use,” has been updated to “Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), 2 or 3 dose schedule, for intramuscular use.”

Code 90651, previously “Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 3 dose schedule, for intramuscular use,” has been updated to “Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use.”

Code 90587 is new and is defined as “Dengue vaccine, quadrivalent, live, 3 dose schedule, for subcutaneous use.” Though it has been proposed by the AMA, the code is still waiting for official FDA approval.

Code 90756 is the newest vaccination code and is defined as “Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5mL dosage, for intramuscular use.”

All codes besides 90756 were released by the AMA back on January 1st and officially went into effect on July 1st. Code 90756 was just released on July 1st and will not go into effect until January 1st of next year. All five codes will be included in the 2018 version of the CPT handbook, which is available for preorder and will be released to the public on October 23rd, 2017.